Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€13.03
12.12.22
-
12.12.23
-45.21%
02.04.23

buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.39
12.12.22
€7.00
12.12.23
-60.16%
24.12.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Little innovation
CEWE Stiftung & Co KGaA

Start price
Target price
Perf. (%)
€90.60
12.12.22
-
12.12.23
7.51%
13.12.23

buy
Airbus Group SE

Start price
Target price
Perf. (%)
€114.08
12.12.22
-
12.01.23
-0.32%
12.12.22

buy
Encavis AG

Start price
Target price
Perf. (%)
€18.92
12.12.22
-
08.01.26
0.40%
16.01.23

Patriot Battery Metals Inc.

Start price
Target price
Perf. (%)
€5.66
12.12.22
-
12.12.23
50.88%
24.04.23

Risky Investment
buy
SMA Solar Technology AG

Start price
Target price
Perf. (%)
€66.50
12.12.22
-
08.01.26
15.56%
11.01.23

buy
Vestas Wind Systems A/S

Start price
Target price
Perf. (%)
€26.68
12.12.22
-
08.01.26
3.19%
09.01.23

buy
Northern Data AG

Start price
Target price
Perf. (%)
€6.92
12.12.22
-
12.12.23
31.38%
13.01.23

buy
2G Energy AG

Start price
Target price
Perf. (%)
€24.95
12.12.22
-
14.08.24
-19.44%
14.08.24

buy
United Natural Foods

Start price
Target price
Perf. (%)
€36.95
12.12.22
-
12.12.23
-22.86%
08.03.23

buy
Dr. Hoenle AG

Start price
Target price
Perf. (%)
€20.25
12.12.22
€23.00
12.12.23
-24.94%
08.10.23

Standard Investments for future growth
Sustainability is important
Higher risks for its business
Significant cyclical dependencies
buy
Porsche Automobil Holding SE

Start price
Target price
Perf. (%)
€56.20
12.12.22
€65.00
12.12.23
-18.40%
08.10.23

Fair valuation
Good rating
Differentiated customer and product portfolio
Higher risks for its business
buy
Encavis AG

Start price
Target price
Perf. (%)
€18.88
12.12.22
€21.00
12.12.23
-35.89%
08.10.23

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
buy
Stem Inc.

Start price
Target price
Perf. (%)
€10.10
12.12.22
€14.00
12.12.23
-18.32%
24.12.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
buy
Polestar Automotive Holding Uk

Start price
Target price
Perf. (%)
€5.60
12.12.22
€8.00
12.12.23
-8.93%
24.12.22

buy
Livent Corp.

Start price
Target price
Perf. (%)
€22.41
12.12.22
€30.00
12.12.23
-17.41%
24.12.22

EBIT growth > 30% per year expected
Fair valuation
Differentiated customer and product portfolio
Very low/no dividend yield expected
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€49.78
12.12.22
€75.00
12.12.23
-6.91%
24.12.22

buy
NIO Inc.

Start price
Target price
Perf. (%)
€11.80
12.12.22
€16.00
12.12.23
-20.34%
24.12.22

buy
Oncosec Medical Inc.

Start price
Target price
Perf. (%)
€2.08
12.12.22
-
12.12.23
-16.54%
24.12.22

buy
TOP Ships Inc.

Start price
Target price
Perf. (%)
€1.34
12.12.22
-
12.12.23
-11.24%
24.12.22

Could be worthwhile Investment >10% per year
Very capable Management
Little innovation
Few uniques
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€4.77
12.12.22
-
12.12.23
-33.89%
27.12.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Galaxy Digital Holdings Ltd.

Start price
Target price
Perf. (%)
€2.82
12.12.22
-
12.12.23
8.91%
09.01.23

Very high cyclical dependencies
Probably not worthwhile Investment
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€3.98
12.12.22
-
12.12.23
1.61%
09.01.23

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Hive Digital Technologies Ltd.

Start price
Target price
Perf. (%)
€1.80
12.12.22
-
12.12.23
71.11%
22.01.23

Could be worthwhile Investment >10% per year
Significant cyclical dependencies